Skip to main content
. 2023 Feb 16;24(4):4014. doi: 10.3390/ijms24044014

Figure 1.

Figure 1

A schematic view of liquid biopsy. Blood collected from cancer patients contains circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), exosomes, and circulating tumor microRNA (ct-miRNA). These biomarkers could provide real-time information on tumor progression, prognosis, and treatment response.